302 related articles for article (PubMed ID: 26842230)
1. A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress.
Yazici C; Köse K; Utaş S; Tanrikulu E; Taşlidere N
Arch Dermatol Res; 2016 Apr; 308(3):207-12. PubMed ID: 26842230
[TBL] [Abstract][Full Text] [Related]
2. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
3. Protein oxidation status in patients with ankylosing spondylitis.
Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
[TBL] [Abstract][Full Text] [Related]
4. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
[TBL] [Abstract][Full Text] [Related]
5. Malondialdehyde and advanced oxidation protein products are not increased in psoriasis: a controlled study.
Skoie IM; Dalen I; Omdal R; Jonsson G
Arch Dermatol Res; 2019 May; 311(4):299-308. PubMed ID: 30830309
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
7. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers are increased since early stages of infection in syphilitic patients.
Hébert-Schuster M; Borderie D; Grange PA; Lemarechal H; Kavian-Tessler N; Batteux F; Dupin N
Arch Dermatol Res; 2012 Nov; 304(9):689-97. PubMed ID: 23011658
[TBL] [Abstract][Full Text] [Related]
9. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
Venturini D; Simão AN; Dichi I
Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
[TBL] [Abstract][Full Text] [Related]
10. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
11. A plasma oxidative stress global index in early stages of chronic venous insufficiency.
Condezo-Hoyos L; Rubio M; Arribas SM; España-Caparrós G; Rodríguez-Rodríguez P; Mujica-Pacheco E; González MC
J Vasc Surg; 2013 Jan; 57(1):205-13. PubMed ID: 23182154
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):789-96. PubMed ID: 20002653
[TBL] [Abstract][Full Text] [Related]
13. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.
Kanelleas A; Liapi C; Katoulis A; Stavropoulos P; Avgerinou G; Georgala S; Economopoulos T; Stavrianeas NG; Katsambas A
Clin Exp Dermatol; 2011 Dec; 36(8):845-50. PubMed ID: 21790728
[TBL] [Abstract][Full Text] [Related]
14. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients.
Witko-Sarsat V; Gausson V; Nguyen AT; Touam M; Drüeke T; Santangelo F; Descamps-Latscha B
Kidney Int; 2003 Jul; 64(1):82-91. PubMed ID: 12787398
[TBL] [Abstract][Full Text] [Related]
15. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash.
Başkol M; Dolbun Seçkin K; Başkol G
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():32-7. PubMed ID: 25910362
[TBL] [Abstract][Full Text] [Related]
16. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
17. Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?
Skutnik-Radziszewska A; Maciejczyk M; Fejfer K; Krahel J; Flisiak I; Kołodziej U; Zalewska A
Oxid Med Cell Longev; 2020; 2020():9086024. PubMed ID: 31998446
[TBL] [Abstract][Full Text] [Related]
18. Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols.
Garibaldi S; Barisione C; Marengo B; Ameri P; Brunelli C; Balbi M; Ghigliotti G
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075404
[TBL] [Abstract][Full Text] [Related]
19. Serum elafin as a potential inflammatory marker in psoriasis.
Elgharib I; Khashaba SA; Elsaid HH; Sharaf MM
Int J Dermatol; 2019 Feb; 58(2):205-209. PubMed ID: 30198145
[TBL] [Abstract][Full Text] [Related]
20. Thyroid Hormone Withdrawal Further Exacerbates Oxidative Stress in Patients with Thyroid Carcinoma.
Unluhizarci K; Kiris A; Kose K; Tanrikulu E; Karaca Z; Tanriverdi F; Kelestimur F
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):225-9. PubMed ID: 26824286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
